The Big Tech earnings next week could revive a flagging market, or at least give investors direction into where stocks are going
Tag: Abbvie Inc
Thursday’s stocks with upside like Nvidia
Here are Thursday’s biggest calls on Wall Street: Wells Fargo reiterates Bank of America as overweight Wells Fargo raised its price target
Here are Jim Cramer’s rapid-fire takeaways on 6 stocks in the news Friday
Clorox – The consumer products giant saw a huge earnings beat. It’s also rebounding from last year’s cyberattack. “Things are back online,
Stock market today: Live updates
Traders work on the floor at the New York Stock Exchange on Feb. 1, 2024. Brendan Mcdermid | Reuters S&P 500 futures
Big pharma Merck, Bristol Myers, J&J prepare to lose revenue
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSE Big pharmaceutical companies such as Bristol Myers
Cramer names biopharma companies as industry mergers start to accrue
CNBC’s Jim Cramer on Friday pointed out the number of biopharma mergers and acquisitions that have closed or been announced over the
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating patients, some
Where M&A could be heading in the obesity drug space
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly
Pfizer 2024 revenue, profit forecast disappoints
Shares of Pfizer fell Wednesday after the drugmaker forecast 2024 revenue and profit below Wall Street’s expectations, as it sees weak demand
Analysts love this biotech stock and give it major upside
The biotechnology sector has finally picked up steam after a tough 2022 — and one under-the-radar stock stands out to fund manager
No More Posts Available.
No more pages to load.